3M Drug Delivery Systems is expanding its capabilities with a new lab site at its Singapore facility in Yishun. The Singapore lab will develop products in both the inhalation and transdermal drug delivery categories for pharmaceutical customers in the Asia Pacific region. The facility houses both a feasibility lab and two process development labs.

“Expanding our presence in Singapore will help us provide Asia Pacific customers with a product development service that has both local and global capabilities,” said Jim Vaughan, vice president and general manager, 3M Drug Delivery Systems Division. “Our team in Singapore understands the region’s regulatory requirements, and is able to quickly respond to customer needs. Additionally, our global laboratory network helps us deliver the outstanding quality the 3M brand is known for.”

The lab is 3M Drug Delivery Systems’ first contract R&D facility in the Asia Pacific region dedicated to pharmaceutical product development. Products developed by the Singapore lab will be suitable for manufacture in 3M’s global network of manufacturing sites in St. Paul, MN, and Loughborough, U.K, and will be developed to conform to global standards.